Belvedere Trading LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Belvedere Trading LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$128,911
-54.5%
15,420
+35.1%
0.00%
Q2 2023$283,424
-77.7%
11,410
-89.4%
0.00%
-100.0%
Q4 2022$1,272,447
+1067.4%
107,561
+431.4%
0.00%0.0%
Q3 2022$109,000
-19.9%
20,242
-6.5%
0.00%
-25.0%
Q2 2022$136,000
+11.5%
21,646
+28.5%
0.00%
+33.3%
Q1 2022$122,00016,8420.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,647,000$6,423,0000.45%
DAFNA Capital Management LLC 75,000$293,0000.30%
Baker Brothers Advisors 2,199,656$8,579,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 71,105$277,0000.05%
SMITH ASSET MANAGEMENT GROUP LP 196,684$767,0000.03%
SABBY MANAGEMENT, LLC 66,000$257,0000.02%
THOMPSON DAVIS & CO., INC. 1,000$4,0000.01%
COLUMBUS CIRCLE INVESTORS 161,919$631,0000.00%
JENNISON ASSOCIATES LLC 455,271$1,776,0000.00%
BlackRock Fund Advisors 448,445$1,749,0000.00%
View complete list of TG THERAPEUTICS INC shareholders